BNP Paribas Financial Markets Invests $378,000 in Viemed Healthcare, Inc. (NASDAQ:VMD)

BNP Paribas Financial Markets bought a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 47,118 shares of the company's stock, valued at approximately $378,000. BNP Paribas Financial Markets owned 0.12% of Viemed Healthcare at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. JPMorgan Chase & Co. raised its stake in shares of Viemed Healthcare by 151.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company's stock worth $724,000 after buying an additional 59,538 shares during the period. SG Americas Securities LLC raised its stake in Viemed Healthcare by 193.1% in the 4th quarter. SG Americas Securities LLC now owns 35,579 shares of the company's stock valued at $285,000 after purchasing an additional 23,442 shares during the last quarter. Rhumbline Advisers raised its stake in Viemed Healthcare by 15.5% in the 4th quarter. Rhumbline Advisers now owns 46,836 shares of the company's stock valued at $376,000 after purchasing an additional 6,275 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in Viemed Healthcare in the 4th quarter valued at $1,549,000. Finally, EntryPoint Capital LLC acquired a new position in Viemed Healthcare in the 4th quarter valued at $92,000. 74.24% of the stock is owned by institutional investors and hedge funds.

Viemed Healthcare Price Performance

NASDAQ VMD traded down $0.03 during mid-day trading on Wednesday, hitting $6.57. The stock had a trading volume of 116,733 shares, compared to its average volume of 140,677. The firm's 50 day moving average is $6.86 and its 200 day moving average is $7.73. Viemed Healthcare, Inc. has a twelve month low of $6.14 and a twelve month high of $9.81. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The stock has a market capitalization of $259.67 million, a price-to-earnings ratio of 24.33 and a beta of 1.49.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The firm had revenue of $59.10 million during the quarter, compared to the consensus estimate of $60.60 million.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.